HLA-G and neoplasm: Tumor cells can alter the expression of HLA class I to escape immune surveillance through a variety of mechanisms, e.g., deficient synthesis of β2-microglobulin, loss of genes encoding heavy chains of HLA antigens, mutations that inhibit HLA antigen transcription, and defects in one or more components of antigen processing machinery components (APM) (36).